Internal Medicine, Medical Oncology · Dallas, TX
NPI
1821257072
Since 2008
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3410 Worth St
Dallas, TX, 75246
Phone (214) 370-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
87,628 services
Medicare patients, 2024
480
Average age 74
Drug cost, 2024
$1.2M
559 prescriptions
Company payments, 2025
$16K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew S Paulson was code J1453 (injection, fosaprepitant, 1 mg), 10,650 times for 53 patients. In total Andrew S Paulson billed 87,628 services in 173 codes, and Medicare paid $1.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1453 Injection, fosaprepitant, 1 mg | Office | 10,650 | 53 | $0.11 | $1,208 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 8,800 | 29 | $44.88 | $395K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 5,779 | 61 | $0.10 | $589 |
| J1930 Injection, lanreotide, 1 mg | Office | 5,760 | 19 | $37.54 | $216K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 5,600 | 16 | $0.06 | $318 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 5,220 | 16 | $39.09 | $204K |
| J9267 Injection, paclitaxel, 1 mg | Office | 3,575 | 20 | $0.08 | $284 |
| J9299 Injection, nivolumab, 1 mg | Office | 3,440 | 11 | $24.70 | $85K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,436 | 90 | $0.09 | $129 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,030 | 73 | $0.71 | $729 |
| 80053 Clinical Chemistry | Office | 558 | 132 | $10.35 | $5,775 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 540 | 37 | $0.25 | $134 |
| 36415 Venipuncture Blood Collection | Office | 537 | 128 | $8.65 | $4,645 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 521 | 21 | $3.53 | $1,838 |
| 85025 Blood Count | Office | 520 | 133 | $7.61 | $3,957 |
By year: 2022 $1.7M for 77,654 services; 2023 $1.3M for 61,231 services; 2024 $1.8M for 87,628 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 558 | 132 | $10.35 | $5,775 |
| 36415 Venipuncture Blood Collection | 537 | 128 | $8.65 | $4,645 |
| 85025 Blood Count | 520 | 133 | $7.61 | $3,957 |
| 82378 Clinical Chemistry | 158 | 41 | $18.58 | $2,936 |
| 85055 Blood Count | 37 | 18 | $35.03 | $1,296 |
| 85007 Blood Count | 16 | 11 | $3.72 | $59.52 |
| 85027 Blood Count | 16 | 11 | $6.34 | $101 |
Medicare prescription drug claims, 2024
In 2024, the drug Andrew S Paulson prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 39 prescriptions and refills. In total Andrew S Paulson wrote 559 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 39 | 39 | 11 | $1,174 |
| Furosemide Generic | 37 | 51 | 13 | $126 |
| Ondansetron Hcl Generic | 27 | 27 | Under 11 | $228 |
| Creon Lipase/Protease/Amylase | 27 | 32 | Under 11 | $56K |
| Xermelo Telotristat Etiprate | 26 | 26 | Under 11 | $236K |
| Eliquis Apixaban | 20 | 20 | Under 11 | $11K |
| Imatinib Mesylate Generic | 19 | 21 | Under 11 | $2,209 |
| Omeprazole Generic | 18 | 22 | Under 11 | $204 |
| Opium Tincture Generic | 17 | 18 | Under 11 | $1,184 |
| Spironolactone Generic | 16 | 26 | Under 11 | $144 |
| Octreotide Acetate Generic | 16 | 16 | Under 11 | $6,637 |
| Oxycodone Hcl Generic | 15 | 15 | Under 11 | $401 |
| Tibsovo Ivosidenib | 13 | 13 | Under 11 | $430K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 12 | 12 | Under 11 | $329 |
| Lorazepam Generic | 12 | 12 | Under 11 | $44.67 |
Brand drugs: 158 claims; generic drugs: 384 claims; opioid claims: 88.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew S Paulson $16K ($16K in general payments such as food, travel and fees) from 21 companies. The largest payer was Exelixis Inc. with $4,700.
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. EXEL | 3 | $4,700 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $3,010 |
| Amgen Inc. AMGN | 1 | $2,744 |
| Janssen Global Services, LLC JNJ | 1 | $2,420 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $2,180 |
| Aadi Bioscience, Inc. | 1 | $530 |
| TerSera Therapeutics LLC | 1 | $35.96 |
| Abbvie Inc. ABBV | 1 | $18.46 |
| Tempus AI, Inc TEM | 1 | $14.71 |
| Sirtex Medical Inc | 1 | $11.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.